SLOUGH,
United Kingdom and RICHMOND,
Va., Feb. 20, 2025 /PRNewswire/ -- Indivior PLC
(Nasdaq/LSE: INDV) today announced its financial results for the
period ending December 31, 2024. The
earnings release, investor presentation and webcast are available
at www.indivior.com.
- The earnings release can be found at
www.indivior.com/investors
- The investor presentation can be found at
www.indivior.com/investors (at 7:00 am
ET)
There will be a live webcast presentation at 13:00 BST (8:00 am
ET) hosted by Mark Crossley,
CEO. The details are below.
Webcast link: https://edge.media-server.com/mmc/p/bfut8veu
Participants may access the presentation telephonically by
registering with the following link:
https://register.vevent.com/register/BIb27314d7848f43e682309a38029a2114
(Registrants will have an option to be called back directly
immediately prior to the call or be provided a call-in # with a
unique pin code following their registration)
About Indivior
Indivior is a global pharmaceutical company working to help
change patients' lives by developing medicines to treat substance
use disorders (SUD). Our vision is that all patients around the
world will have access to evidence-based treatment for the chronic
conditions and co-occurring disorders of SUD. Indivior is dedicated
to transforming SUD from a global human crisis to a recognized and
treated chronic disease. Building on its global portfolio of OUD
treatments, Indivior has a pipeline of product candidates designed
to expand on its heritage in this category. Headquartered in
the United States in Richmond, VA, Indivior employs over 1,000
individuals globally and its portfolio of products is available in
over 30 countries worldwide. Visit www.indivior.com to learn more.
Connect with Indivior on LinkedIn by
visiting www.linkedin.com/company/indivior.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/indivior-announces-fy-and-q4-2024-financial-results-302379345.html
SOURCE Indivior PLC
